Patent: 9,120,873
✉ Email this page to a colleague
Summary for Patent: 9,120,873
Title: | Recombinantly produced human factor VIII and IX |
Abstract: | A recombinant human factor VIII or IX protein having a human glycosylation pattern but the protein is devoid of N-glycolylneuraminic acid and/or the carbohydrate group Gal.alpha.-3Gal. |
Inventor(s): | Sandberg; Helena (Bromma, SE), Stenlund; Peter (Bromma, SE), Schroder; Carola (Neuried, DE), Casademunt; Elisabeth (Munchen, DE), Tiemeyer; Maya (Munchen, DE) |
Assignee: | Octapharma AG (Lachen, CH) |
Application Number: | 12/737,815 |
Patent Claims: | see list of patent claims |
Details for Patent 9,120,873
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Baxalta Us Inc. | VONVENDI | von willebrand factor (recombinant) | For Injection | 125577 | 12/08/2015 | ⤷ Try a Trial | 2028-08-21 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |